AGE Old Analysis
| AGEDelisted Stock | USD 0.74 0.01 1.37% |
AGE Old is overvalued with Real Value of 0.6 and Hype Value of 0.74. The main objective of AGE Old delisted stock analysis is to determine its intrinsic value, which is an estimate of what AGE Old is worth, separate from its market price. There are two main types of AGE Old's stock analysis: fundamental analysis and technical analysis.
The AGE Old stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and AGE Old's ongoing operational relationships across important fundamental and technical indicators.
AGE |
AGE Stock Analysis Notes
About 76.0% of the company shares are held by company insiders. The company recorded a loss per share of 13.36. AGE Old had not issued any dividends in recent years. The entity had 28:1000 split on the 15th of March 2024. AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. AgeX Therapeutics, Inc. was incorporated in 2017 and is based in Alameda, California. Agex Therapeutics operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 5 people. For more info on AGE Old please contact Michael West at 510 671 8370 or go to https://www.agexinc.com.AGE Old Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. AGE Old's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding AGE Old or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| AGE Old is now traded under the symbol SER. Please update your portfolios or report it if you believe this is an error. Report It! | |
| AGE Old is not yet fully synchronised with the market data | |
| AGE Old has some characteristics of a very speculative penny stock | |
| AGE Old has a very high chance of going through financial distress in the upcoming years | |
| AGE Old has 4.37 M in debt with debt to equity (D/E) ratio of 0.75, which is OK given its current industry classification. AGE Old has a current ratio of 0.19, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for AGE to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 142 K. Reported Net Loss for the year was (14.8 M) with profit before taxes, overhead, and interest of 125 K. | |
| AGE Old has about 645 K in cash with (7.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 76.0% of AGE Old shares are held by company insiders |
AGE Old Upcoming and Recent Events
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
AGE Market Capitalization
The company currently falls under 'Micro-Cap' category with a total capitalization of 31.51 M.AGE Old Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific AGE Old insiders, such as employees or executives, is commonly permitted as long as it does not rely on AGE Old's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases AGE Old insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Michael West over six months ago Acquisition by Michael West of 3125 shares of AgeX Therapeutics subject to Rule 16b-3 | ||
Renondin Jeanchristophe over a year ago AgeX Therapeutics exotic insider transaction detected | ||
Juvenescence Ltd over a year ago Acquisition by Juvenescence Ltd of 756429 shares of AgeX Therapeutics subject to Rule 16b-3 | ||
Juvenescence Ltd over a year ago Bona fide gift to Juvenescence Ltd of 16447500 shares of AgeX Therapeutics subject to Section 16 | ||
Juvenescence Ltd over a year ago Acquisition by Juvenescence Ltd of 801924 shares of AgeX Therapeutics subject to Rule 16b-3 | ||
Juvenescence Ltd over a year ago Acquisition by Juvenescence Ltd of 340136 shares of AgeX Therapeutics subject to Rule 16b-3 |
About AGE Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how AGE Old prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AGE shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as AGE Old. By using and applying AGE Stock analysis, traders can create a robust methodology for identifying AGE entry and exit points for their positions.
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. AgeX Therapeutics, Inc. was incorporated in 2017 and is based in Alameda, California. Agex Therapeutics operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 5 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding AGE Old to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in AGE Stock
If you are still planning to invest in AGE Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AGE Old's history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |